Development of a new model system to dissect isoform specific Akt signalling in adipocytes

Biochemical Journal

Volumn 468, Issue 3, 2015, Pages 425-434

  Kajno, Esi ^a   McGraw, Timothy E ^a   Gonzalez, Eva ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Adipocyte; Adipogenesis; Akt isoform signalling; Glucose transporter 4 (GLUT4); Insulin action; MK 2206

Indexed keywords

8 [4 (1 AMINOCYCLOBUTYL)PHENYL] 9 PHENYL 1,2,4 TRIAZOLO[3,4 F][1,6]NAPHTHYRIDIN 3(2H) ONE; GLUCOSE TRANSPORTER 4; INSULIN; ISOPROTEIN; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR; AKT1 PROTEIN, MOUSE; AKT2 PROTEIN, MOUSE; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, MOUSE; FUSED HETEROCYCLIC RINGS; PROTEIN KINASE INHIBITOR; RECOMBINANT PROTEIN; SLC2A4 PROTEIN, MOUSE;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE CELL; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; GLUCOSE TRANSPORT; INSULIN METABOLISM; MITOSIS; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WHITE ADIPOSE TISSUE; 3T3 CELL LINE; ALLOSTERISM; AMINO ACID SUBSTITUTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; DRUG RESISTANCE; ENZYMOLOGY; GENETICS; INSULIN RESISTANCE; METABOLISM; MUTATION; RNA INTERFERENCE; WHITE ADIPOCYTE;

3T3-L1 CELLS; ADIPOCYTES, WHITE; ADIPOGENESIS; ALLOSTERIC REGULATION; AMINO ACID SUBSTITUTION; ANIMALS; DRUG RESISTANCE; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSE TRANSPORTER TYPE 4; HETEROCYCLIC COMPOUNDS, 3-RING; INSULIN RESISTANCE; MICE; MUTATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RECOMBINANT PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84934974318     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20150191     Document Type: Article

References (44)

1. Manning, B.D. and Cantley, L.C. (2007) AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274 CrossRef PubMed
2. Whiteman, E.L., Cho, H. and Birnbaum, M.J. (2002) Role of Akt/protein kinase B in metabolism. Trends Endocrinol. Metab 13, 444-451 PubMed
3. Boucher, J., Kleinridders, A. and Kahn, C.R. (2014) Insulin receptor signaling in normal and insulin-resistant states., Cold Spring Harb. Perspect. Biol. 6, pii: a009191 CrossRef
4. Dummler, B. and Hemmings, B.A. (2007) Physiological roles of PKB/Akt isoforms in development and disease. Biochem. Soc. Trans. 35, 231-235 CrossRef PubMed
5. Alessi, D.R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P. and Hemmings, B.A. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541-6551 PubMed
6. Hanada, M., Feng, J. and Hemmings, B.A. (2004) Structure, regulation and function of PKB/AKT-a major therapeutic target. Biochem. Biophys. Acta 1697, 3-16 PubMed
7. Gonzalez, E. and McGraw, T.E. (2009) The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle 8, 2502-2508 CrossRef PubMed
8. George, S., Rochford, J.J., Wolfrum, C., Gray, S.L., Schinner, S., Wilson, J.C., Soos, M.A., Murgatroyd, P.R., Williams, R.M., Acerini, C.L. et al. (2004) A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304, 1325-1328 CrossRef PubMed
9. Cho, H., Mu, J., Kim, J.K., Thorvaldsen, J.L., Chu, Q., Crenshaw, III, E.B., Kaestner, K.H., Bartolomei, M.S., Shulman, G.I. and Birnbaum, M.J. (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292, 1728-1731 CrossRef PubMed
10. Garofalo, R.S., Orena, S.J., Rafidi, K., Torchia, A.J., Stock, J.L., Hildebrandt, A.L., Coskran, T., Black, S.C., Brees, D.J., Wicks, J.R. et al. (2003) Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J. Clin. Invest. 112, 197-208 CrossRef PubMed
11. Hill, M.M., Clark, S.F., Tucker, D.F., Birnbaum, M.J., James, D.E. and Macaulay, S.L. (1999) A role for protein kinase Bbeta/Akt2 in insulin-stimulated GLUT4 translocation in adipocytes. Mol. Cell. Biol. 19, 7771-7781 PubMed
12. Jiang, Z.Y., Zhou, Q.L., Coleman, K.A., Chouinard, M., Boese, Q. and Czech, M.P. (2003) Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc. Natl. Acad. Sci. U.S.A. 100, 7569-7574 CrossRef PubMed
13. Bae, S.S., Cho, H., Mu, J. and Birnbaum, M.J. (2003) Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J. Biol. Chem. 278, 49530-49536 CrossRef PubMed
14. Gonzalez, E. and McGraw, T.E. (2009) Insulin-modulated Akt subcellular localization determines Akt isoform-specific signaling. Proc. Natl. Acad. Sci. U.S.A. 106, 7004-7009 CrossRef PubMed
15. Sano, H., Kane, S., Sano, E., Miinea, C.P., Asara, J.M., Lane, W.S., Garner, C.W. and Lienhard, G.E. (2003) Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J. Biol. Chem. 278, 14599-14602 CrossRef PubMed
16. Eguez, L., Lee, A., Chavez, J.A., Miinea, C.P., Kane, S., Lienhard, G.E. and McGraw, T.E. (2005) Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein. Cell Metab. 2, 263-272 CrossRef PubMed
17. Nakae, J., Kitamura, T., Silver, D.L. and Accili, D. (2001) The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J. Clin. Invest. 108, 1359-1367 CrossRef PubMed
18. Chen, W.S., Xu, P.Z., Gottlob, K., Chen, M.L., Sokol, K., Shiyanova, T., Roninson, I., Weng, W., Suzuki, R., Tobe, K. et al. (2001) Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15, 2203-2208 CrossRef PubMed
19. Cho, H., Thorvaldsen, J.L., Chu, Q., Feng, F. and Birnbaum, M.J. (2001) Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276, 38349-38352 CrossRef PubMed
20. Chen, W.S., Peng, X.D., Wang, Y., Xu, P.Z., Chen, M.L., Luo, Y., Jeon, S.M., Coleman, K., Haschek, W.M., Bass, J. et al. (2009) Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice. Mol. Cell. Biol. 29, 3151-3162 CrossRef PubMed
21. Alaimo, P.J., Shogren-Knaak, M.A. and Shokat, K.M. (2001) Chemical genetic approaches for the elucidation of signaling pathways. Curr. Opin. Chem. Biol. 5, 360-367 CrossRef PubMed
22. Zhao, Z., Robinson, R.G., Barnett, S.F., Defeo-Jones, D., Jones, R.E., Hartman, G.D., Huber, H.E., Duggan, M.E. and Lindsley, C.W. (2008) Development of potent, allosteric dual Akt1 and Akt2 inhibitors with improved physical properties and cell activity. Bioorg. Med. Chem. Lett. 18, 49-53 CrossRef PubMed
23. Zhao, Z., Leister, W.H., Robinson, R.G., Barnett, S.F., Defeo-Jones, D., Jones, R.E., Hartman, G.D., Huff, J.R., Huber, H.E., Duggan, M.E. and Lindsley, C.W. (2005) Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors. Bioorg. Med. Chem. Lett. 15, 905-909 CrossRef PubMed
24. Green, C.J., Goransson, O., Kular, G.S., Leslie, N.R., Gray, A., Alessi, D.R., Sakamoto, K. and Hundal, H.S. (2008) Use of Akt inhibitor and a drug-resistant mutant validates a critical role for protein kinase B/Akt in the insulin-dependent regulation of glucose and system A amino acid uptake. J. Biol. Chem. 283, 27653-27667 CrossRef PubMed
25. Tan, S.X., Ng, Y. and James, D.E. (2010) Akt inhibitors reduce glucose uptake independently of their effects on Akt. Biochem. J. 432, 191-197 CrossRef PubMed
26. Hunter, R.W., Harper, M.T. and Hers, I. (2008) The PKB inhibitor Akti-1/2 potentiates PAR-1-mediated platelet function independently of its ability to block PKB. J. Thromb. Haemost. 6, 1923-1932 CrossRef PubMed
27. Tan, S., Ng, Y. and James, D.E. (2011) Next-generation Akt inhibitors provide greater specificity: effects on glucose metabolism in adipocytes. Biochem. J. 435, 539-544 CrossRef PubMed
28. Hirai, H., Sootome, H., Nakatsuru, Y., Miyama, K., Taguchi, S., Tsujioka, K., Ueno, Y., Hatch, H., Majumder, P.K., Pan, B.S. and Kotani, H. (2010) MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo. Mol. Cancer Ther. 9, 1956-1967 CrossRef PubMed
29. Yap, T.A., Yan, L., Patnaik, A., Fearen, I., Olmos, D., Papadopoulos, K., Baird, R.D., Delgado, L., Taylor, A., Lupinacci, L. et al. (2011) First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors. J. Clin. Oncol. 29, 4688-4695 CrossRef PubMed
30. Lai, Y.C., Liu, Y., Jacobs, R. and Rider, M.H. (2012) A novel PKB/Akt inhibitor, MK-2206, effectively inhibits insulin-stimulated glucose metabolism and protein synthesis in isolated rat skeletal muscle. Biochem. J. 447, 137-147 CrossRef PubMed
31. Gonzalez, E. and McGraw, T.E. (2006) Insulin signaling diverges into Akt-dependent and -independent signals to regulate the recruitment/docking and the fusion of GLUT4 vesicles to the plasma membrane. Mol. Biol. Cell 17, 4484-4493 CrossRef PubMed
32. Karylowski, O., Zeigerer, A., Cohen, A. and McGraw, T.E. (2004) GLUT4 is retained by an intracellular cycle of vesicle formation and fusion with endosomes. Mol. Biol. Cell 15, 870-882 CrossRef PubMed
33. Lampson, M.A., Racz, A., Cushman, S.W. and McGraw, T.E. (2000) Demonstration of insulin-responsive trafficking of GLUT4 and vpTR in fibroblasts. J. Cell Sci. 113 (Pt 22), 4065-4076 PubMed
34. Gonzalez, E., Flier, E., Molle, D., Accili, D. and McGraw, T.E. (2011) Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor. Proc. Natl. Acad. Sci. U.S.A. 108, 10162-10167 CrossRef PubMed
35. Zeigerer, A., Lampson, M.A., Karylowski, O., Sabatini, D.D., Adesnik, M., Ren, M. and McGraw, T.E. (2002) GLUT4 retention in adipocytes requires two intracellular insulin-regulated transport steps. Mol. Biol. Cell. 13, 2421-2435 CrossRef PubMed
36. Wu, W.I., Voegtli, W.C., Sturgis, H.L., Dizon, F.P., Vigers, G.P. and Brandhuber, B.J. (2010) Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition. PLoS One 5, e12913 CrossRef PubMed
37. Chan, T.O., Zhang, J., Rodeck, U., Pascal, J.M., Armen, R.S., Spring, M., Dumitru, C.D., Myers, V., Li, X., Cheung, J.Y. and Feldman, A.M. (2011) Resistance of Akt kinases to dephosphorylation through ATP-dependent conformational plasticity. Proc. Natl. Acad. Sci. U.S.A. 108, E1120-E1127 CrossRef PubMed
38. Tan, S.X., Ng, Y., Meoli, C.C., Kumar, A., Khoo, P.S., Fazakerley, D.J., Junutula, J.R., Vali, S., James, D.E. and Stockli, J. (2012) Amplification and demultiplexing in insulin-regulated Akt protein kinase pathway in adipocytes. J. Biol. Chem. 287, 6128-6138 CrossRef PubMed
39. Calera, M.R., Martinez, C., Liu, H., Jack, A.K., Birnbaum, M.J. and Pilch, P.F. (1998) Insulin increases the association of Akt-2 with Glut4-containing vesicles. J. Biol. Chem. 273, 7201-7204 CrossRef PubMed
40. Yun, S.J., Kim, E.K., Tucker, D.F., Kim, C.D., Birnbaum, M.J. and Bae, S.S. (2008) Isoform-specific regulation of adipocyte differentiation by Akt/protein kinase Balpha. Biochem. Biophys. Res. Commun. 371, 138-143 CrossRef PubMed
41. Baudry, A., Yang, Z.Z. and Hemmings, B.A. (2006) PKBalpha is required for adipose differentiation of mouse embryonic fibroblasts. J. Cell Sci. 119, 889-897 CrossRef PubMed
42. Brown, M.S. and Goldstein, J.L. (2008) Selective versus total insulin resistance: a pathogenic paradox. Cell Metab. 7, 95-96 CrossRef PubMed
43. Rehan, M., Beg, M.A., Parveen, S., Damanhouri, G.A. and Zaher, G.F. (2014) Computational insights into the inhibitory mechanism of human AKT1 by an orally active inhibitor, MK-2206. PLoS One 9, e109705 CrossRef PubMed
44. Peng, X.D., Xu, P.Z., Chen, M.L., Hahn-Windgassen, A., Skeen, J., Jacobs, J., Sundararajan, D., Chen, W.S., Crawford, S.E., Coleman, K.G. and Hay, N. (2003) Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 17, 1352-1365 CrossRef PubMed